HXBM — Helix BioMedix Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro Cap

Annual cashflow statement for Helix BioMedix, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2007 December 31st	2008 December 31st	2009 December 31st	2010 December 31st	2011 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-3.43	-4.52	-3.78	-7.71	-2.49
Depreciation
Amortisation
Non-Cash Items	0.163	1.35	0.669	4.93	0.237
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-0.115	-0.107	-0.096	-0.131	-0.154
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities	-3.21	-3.14	-3.07	-2.8	-2.3
Capital Expenditures	-0.027	-0.03	-0.043	-0.005	-0.023
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Software Development Costs
Other Investing Cash Flow Items	0.28	-0.27	0.97	-0.35	-0.036
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	0.253	-0.3	0.927	-0.355	-0.059
Financing Cash Flow Items	0	0.97	0	0	—
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	2.14	3.96	2.5	5.85	0
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-0.816	0.524	0.36	2.7	-2.36